Работы, на которые ссылается эта работа

Работ: 90

Работа: Next-generation CAR-T and CAR-NK cell therapies in hematologic malignancies: engineering for persistence, specificity, and safety

Unveiling the potential of CLL-1: a promising target for AML therapy
Hamed Soleimani Samarkhazan, Sara Zehtabcheh, Hamideh Rahmani Seraji +4
Обзорная статья2025Цитирований: 6
ABI
Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence
Beatrice Aramini, Valentina Masciale, Giulia Grisendi +8
Обзорная статья2022Цитирований: 6
ABI
Targeting cancer stem cells with CAR-based immunotherapy: biology, evidence, and future directions
Kaveh Hadiloo, Parsa Mostanadi, Ali Asadzadeh +2
Обзорная статья2025Цитирований: 6
ABI
Targeting cancer stem cell pathways for cancer therapy
Liqun Yang, Pengfei Shi, Gaichao Zhao +8
Обзорная статья2020Цитирований: 5
ABI
Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies
Xinyi Xiao, Shengkang Huang, Sifei Chen +4
Обзорная статья2021Цитирований: 5
ABI
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Lei Peng, Giacomo Sferruzza, Luojia Yang +2
Обзорная статья2024Цитирований: 5
ABI
The clinical landscape of CAR NK cells
Lasse Vedel Jørgensen, Emil Birch Christensen, Mike Bogetofte Barnkob +1
Обзорная статья2025Цитирований: 5
ABI
Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
Justin Eyquem, Jorge Mansilla‐Soto, Theodoros Giavridis +6
Статья2017Цитирований: 4
ABI
CAR-T Cell Performance: How to Improve Their Persistence?
Gina López-Cantillo, Claudia Urueña, Bernardo Camacho +1
Обзорная статья2022Цитирований: 4
ABI
The tumor microenvironment’s role in the response to immune checkpoint blockade
Konstantinos Aliazis, Anthos Christofides, Rushil Shah +4
Обзорная статья2025Цитирований: 4
ABI
Cancer Stem Cell Plasticity – A Deadly Deal
Archana P. Thankamony, Kritika Saxena, Reshma Murali +2
Обзорная статья2020Цитирований: 4
ABI
Targeting HIF1α Eliminates Cancer Stem Cells in Hematological Malignancies
Yin Wang, Yan Liu, Sami N. Malek +2
Статья2011Цитирований: 3
ABI
Engineering and Design of Chimeric Antigen Receptors
Sònia Guedan, Hugo Calderón, Avery D. Posey +1
Обзорная статья2018Цитирований: 3
ABI
Single-cell-guided identification of logic-gated antigen combinations for designing effective and safe CAR therapy
Sanna Madan, Tiangen Chang, Alexandra R. Harris +15
Препринт2025Цитирований: 3
ABI
Cancer stem cells (CSCs) in cancer progression and therapy
Masoud Najafi, Bagher Farhood, Keywan Mortezaee
Обзорная статья2018Цитирований: 3
ABI
CAR-T cell combination therapy: the next revolution in cancer treatment
Maysoon Al‐Haideri, Santalia Banne Tondok, Salar Hozhabri Safa +8
Обзорная статьяCAR-T cell therapy researchCancer Cell International2022Цитирований: 2
ABI
In vivo CAR T cell generation to treat cancer and autoimmune disease
Theresa Hunter, Yanjie Bao, Yan Zhang +37
Статья2025Цитирований: 2
ABI
Combined CD28 and 4-1BB Costimulation Potentiates Affinity-tuned Chimeric Antigen Receptor–engineered T Cells
Esther Drent, Renée Poels, Ruud Ruiter +9
Статья2019Цитирований: 2
ABI
Therapies targeting cancer stem cells: Current trends and future challenges
Denisa Dragu
Статья2015Цитирований: 2
ABI
Targeting the tumour stroma to improve cancer therapy
Kenneth C. Valkenburg, Amber E. de Groot, Kenneth J. Pienta
Обзорная статья2018Цитирований: 2
ABI
Tumor-associated macrophages: role in tumorigenesis and immunotherapy implications
Shunyao Zhu, Ziyi Luo, Xixi Li +3
Обзорная статья2020Цитирований: 2
ABI
Biomarkers of Cancer Stem Cells for Experimental Research and Clinical Application
Shigeo Saito, Chia‐Chen Ku, Kenly Wuputra +5
Обзорная статья2022Цитирований: 2
ABI
m6A readers, writers, erasers, and the m6A epitranscriptome in breast cancer
Belinda J. Petri, Carolyn M. Klinge
Обзорная статья2022Цитирований: 2
ABI
M6A Demethylase ALKBH5 in Human Diseases: From Structure to Mechanisms
Miaochun Fang, Liwen Ye, Yue Zhu +2
Обзорная статья2025Цитирований: 2
ABI
CAR-T Cell Therapy: the Efficacy and Toxicity Balance
Karan Chohan, Elizabeth L. Siegler, Saad S. Kenderian
Обзорная статья2023Цитирований: 2
ABI